Related Experiment Video
Updated: Aug 1, 2025

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
ME2 Promotes Hepatocellular Carcinoma Cell Migration through Pyruvate
Yanting Yang1, Zhenxi Zhang1, Wei Li1
1State Key Laboratory of Medical Molecular Biology, Haihe Laboratory of Cell Ecosystem, Department of Cell Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
Malic enzyme 2 (ME2) drives liver cancer cell migration and invasion by increasing pyruvate. Pyruvate directly interacts with β-catenin, promoting cancer cell movement and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer metastasis remains a significant clinical challenge.
- Cell migration and invasion are critical early steps in metastasis.
- The molecular mechanisms regulating these processes are not fully elucidated.
Purpose of the Study:
- To investigate the role of malic enzyme 2 (ME2) in human liver cancer cell migration and invasion.
- To elucidate the underlying molecular mechanisms by which ME2 influences these processes.
Main Methods:
- Utilized human liver cancer cell lines (SK-Hep1 and Huh7).
- Manipulated malic enzyme 2 (ME2) expression through depletion and overexpression.
- Assessed cell migration and invasion assays.
- Investigated the interaction between pyruvate and β-catenin.
Main Results:
- Depletion of ME2 significantly reduced cancer cell migration and invasion.
- Overexpression of ME2 enhanced cancer cell migration and invasion.
- ME2 promotes pyruvate production, which binds to and increases β-catenin protein levels.
- Exogenous pyruvate administration rescued the migratory and invasive phenotypes in ME2-depleted cells.
Conclusions:
- Malic enzyme 2 (ME2) plays a crucial role in promoting liver cancer cell migration and invasion.
- The ME2-pyruvate-β-catenin axis is a key mechanism driving cancer cell motility and invasiveness.
- Targeting ME2 or its downstream effectors may offer therapeutic strategies for inhibiting liver cancer metastasis.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
07:47Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Cell Migration
Chemotaxis and Direction of Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...